BackMereo Biopharma Group Plc Overview
Mereo Biopharma Group Plc - ADR

Mereo Biopharma Group Plc Discounted Cash Flow

DCF Analysis for MREO.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.26

Current Fair Value

$0.26
17.4% Downside

Overvalued by 17.4% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading